Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2023 Earnings Call Transcript August 9, 2023
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.14.
Operator: Good day, and welcome to the Inovio Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is...
